Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and
Anil Pandit1, Madan Raj Aryal2, Aashrayata Aryal Pandit1
1Division of Cardiovascular Diseases , Mayo Clinic , Scottsdale, Arizona , USA.
Insights
Preventive percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI) significantly reduces cardiovascular deaths. This meta-analysis of randomized trials suggests broader PCI benefits beyond the culprit artery for STEMI patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Trials
Background:
- Randomized trials suggest benefits of preventive percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI).
- Existing trials are underpowered to definitively assess the impact on cardiac mortality.
- A systematic review is needed to consolidate evidence on cardiac death reduction.
Purpose of the Study:
- To systematically review randomized trial evidence on the cardiac mortality benefit of preventive PCI in acute STEMI patients.
- To evaluate the impact of preventive PCI on cardiovascular outcomes in STEMI with multivessel disease.
Main Methods:
- Systematic search of PubMed, Scopus, Cochrane, and clinicaltrials.gov databases up to September 2013.
- Inclusion of randomized clinical trials only, with data abstraction by independent observers.
- Meta-analysis using a fixed-effect model and heterogeneity assessment with I² statistics.
Main Results:
- Three randomized trials involving 748 patients (416 preventive PCI, 332 culprit-only PCI) were analyzed.
- Preventive PCI significantly lowered cardiovascular deaths (OR 0.39, 95% CI 0.18-0.83).
- Reduced risks of repeat revascularization (OR 0.28) and non-fatal myocardial infarction (OR 0.38) were observed with preventive PCI.
Conclusions:
- Preventive PCI in STEMI with multivessel disease is associated with reduced cardiovascular mortality compared to culprit-only PCI.
- These findings suggest a mortality benefit that warrants confirmation.
- Larger, adequately powered randomized clinical trials are recommended to validate these results.
Aim:
The benefit of preventive percutaneous coronary intervention (PCI) in ST elevation myocardial infarction (STEMI) has been shown in randomised trials. However, all the randomised trials are underpowered to detect benefit in cardiac death. We aim to systematically review evidence on the cardiac mortality benefit of preventive PCI in patients presenting with acute STEMI in randomised patient populations.
Methods:
PubMed, Scopus, Cochrane and clinicaltrials.gov databases were searched for studies published until 30 September 2013. The studies were limited to randomised clinical trials. Independent observers abstracted the data on outcomes, characteristics and qualities of studies included. Fixed effect model was employed for meta-analysis. Heterogeneity of studies included was analysed using I(2) statistics.
Results:
In three randomised clinical trials published, involving 748 patients with acute STEMI and multivessel disease, 416 patients were randomised to preventive PCI and 332 to culprit-only PCI. Patients undergoing preventive PCI had significant lower risk of cardiovascular deaths (pooled OR 0.39, 95% CI 0.18 to 0.83, p=0.01, I(2)=0%), repeat revascularisation (pooled OR 0.28, 95% CI 0.18 to 0.44, p=0.00001, I(2)=0%) and non-fatal myocardial infarction (pooled OR 0.38, 95% CI 0.20 to 0.75, p=0.005, I(2)=0%) compared with culprit-only revascularisation.
Conclusions:
In patients presenting with acute STEMI and significant multivessel coronary artery disease, based on our data, preventive PCI is associated with lower risk of cardiovascular mortality compared with primary PCI of only the culprit artery. This finding needs to be confirmed in larger adequately powered randomised clinical trials.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care


